Holen Sie sich die Stockscreener-App
11.85
0.85%
0.10
Handel nachbörslich:
11.85
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Roivant Sciences: Vant Model And IMVT-1402 Create A 2025 Catalyst Stack (NASDAQ:ROIV) - Seeking Alpha
Roivant plans $500M new share repurchase as brepocitinib data readout nears - MSN
Roivant Sciences Ltd. Approaches Psychological Resistance Level2025 Big Picture & Weekly Market Pulse Alerts - 선데이타임즈
Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Just Slashed This Year's Revenue Estimates By 17% - 富途牛牛
Roivant Sciences’ (ROIV) Aggressive Buybacks Amid Losses: Commitment to Shareholders or Growth Uncertainty? - simplywall.st
Roivant Sciences Earnings Call: Progress Amid Challenges - TipRanks
Why Roivant Sciences Stock Bounced Back on Tuesday - Mitrade
Roivant Sciences shares rise 2.91% intraday after announcing a $500 million share repurchase program. - AInvest
Chairman on Gubra CEO change: Henrik Blou wants to try something different - medwatch.com
Leerink Partners raises Roivant Sciences stock price target to $18 on lower share count By Investing.com - Investing.com South Africa
Leerink Partners raises Roivant Sciences stock price target to $18 on lower share count - Investing.com Australia
Roivant Sciences Q1 2025 Earnings Call Highlights: Strong Cash Position and Share Repurchase Amidst Legal and Market Challenges - AInvest
Roivant Sciences Ltd (ROIV) Q1 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Why Roivant Sciences Ltd. stock attracts strong analyst attentionHyper-Growth Screener - classian.co.kr
Roivant Sciences Reports Q1 2025 Financial Results - TipRanks
Roivant Reports Financial Results for the First Quarter Ended June 30, 2025, and Provides Business Update - GlobeNewswire
Why Roivant Sciences Stock Was Slipping on Monday - Mitrade
Roivant Sciences Sees Losses Grow But Investors Hold Steady - Finimize
Roivant Sciences Q1 2026 Earnings Call Transcript - MarketBeat
Roivant Deepens Its Losses But Keeps Investors On Board - Finimize
Roivant Sciences Reports Q1 EPS of 33c, Revenue of $2.17M, and Initiates $1.5B Share Buyback Program - AInvest
A Glimpse of Roivant Sciences's Earnings Potential - 富途牛牛
Roivant Sciences Ltd. announces an Equity Buyback for $500 million worth of its shares. - MarketScreener
Roivant Sciences Completes Equity Buyback Plan with 19.59% of Shares Repurchased - AInvest
Tranche Update on Roivant Sciences Ltd.'s Equity Buyback Plan announced on April 2, 2024. - MarketScreener
Roivant's Q1 2025 Earnings Call: Unraveling the Contradictions in Brepo's DM Market Positioning and Efficacy Expectations - AInvest
Roivant Sciences Ltd. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:ROIV) - Seeking Alpha
Roivant Sciences Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Roivant Sciences Ltd., Q1 2026 Earnings Call, Aug 11, 2025 - MarketScreener
Roivant Sciences Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2025 - MarketScreener
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Roivant Sciences earnings missed by $0.08, revenue fell short of estimates - Investing.com South Africa
Roivant Sciences Q1 Swings to Loss, Revenue Falls - MarketScreener
Biopharma firm Roivant's Q1 revenue declines, net loss widens to $273.9 mln - MarketScreener
Roivant Sciences Ltd. (ROIV) Misses Q1 EPS by 8c - StreetInsider
Earnings Flash (ROIV) Roivant Sciences Ltd. Reports Q1 Revenue $2.2M, vs. FactSet Est of $7.3M - MarketScreener
Earnings Flash (ROIV) Roivant Sciences Posts Fiscal Q1 Net Loss $0.33 a Share, vs. FactSet Est of $0.28 Loss - MarketScreener
Will Roivant Sciences Ltd. outperform the marketAI Intraday Market Movement Prediction Tool - Newser
Will Roivant Sciences Ltd. see short term momentumStrong Buy Signal Summary with Entry Zone - Newser
How high can Roivant Sciences Ltd. stock goDaily Entry Opportunity Forecasting Tool - Newser
Is Roivant Sciences Ltd. stock a good hedge against inflationTechnical Reversal Pattern Summary and Tracker - Newser
Roivant Sciences Earnings Expectations: A Closer Look at the Company's Performance and Analyst Sentiments - AInvest
Roivant Sciences (ROIV) to Release Earnings on Monday - Defense World
What makes Roivant Sciences Ltd. stock price move sharplyChart Driven Opportunity Scanner with Alerts - Newser
Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday - Investing.com Australia
Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday By Investing.com - Investing.com South Africa
What To Expect From Roivant Sciences Ltd (ROIV) Q1 2026 Earnings - Yahoo Finance
Roivant Sciences Ltd. shares fall 1.12% intraday as Sumitomo Pharma submits application for Parkinson's disease treatment. - AInvest
0.44%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):